EUVIMEDEUVIMED entdecken
KohortenstudieOpen Access

Limited Utility of HIV RNA Testing to Monitor Oral Preexposure Prophylaxis Use: A Real-World Cohort Study—United States, 2019–2023

Weiming Zhu iD, Kevin P Delaney iD, Ya-Lin A Huang iD, Rupa R Patel iD, Athena P Kourtis iD, Karen W Hoover iD

Clinical Infectious Diseases · 2025

DOI: 10.1093/cid/ciaf230 ↗

Kurz gefasst

Kohortenstudie in der Zeitschrift Clinical Infectious Diseases, 2025. Verfasst von Weiming Zhu und 5 weiteren Autor:innen. Beteiligte Einrichtung: HIV Research Branch, Division of HIV Prevention, Centers for Disease Control and Prevention, Atlanta, Georgia, USA. Hauptthemen laut MEDLINE: Pre-Exposure Prophylaxis, HIV Infections, RNA, Viral, Anti-HIV Agents. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 12 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: Intramural CDC HHS, centers of disease control and Prevention.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

The 2021 update of the Centers for Disease Control and Prevention clinical guidelines for human immunodeficiency virus (HIV) preexposure prophylaxis (PrEP) recommended both antigen-antibody (Ag/Ab) and RNA testing at PrEP initiation and routine follow-up. We assessed the real-world use and performance of HIV tests among oral PrEP users.

Methods

An oral PrEP user cohort was constructed using the HealthVerity database that included linked diagnoses, laboratory tests, and prescriptions from December 2018 to August 2023. Data were stratified by pre–guideline update (2019−2021) and post–guideline update (2022−2023) periods. For each period, we assessed the agreement between same-day HIV Ag/Ab and RNA results and calculated the false-positive rates and positive predictive values of HIV Ag/Ab and RNA tests compared with the adjudicated HIV status.

Results

The HIV RNA testing rate for follow-up, per 100 person-years, increased from 16 before to 123 after the guideline update. The positivity rate of HIV RNA tests decreased from 1.39% to 0.22%. Overall agreement between Ag/Ab and RNA results remained high. The false-positive rates of HIV Ag/Ab and RNA testing remained similar, but the positive predictive value of HIV RNA testing for PrEP follow-up decreased from 100% to 67%. We estimated that 8226–9900 RNA tests would be needed for 1 HIV diagnosis earlier than would be detected with Ag/Ab testing alone.

Discussion

HIV RNA testing did not provide additional value to Ag/Ab testing during routine follow-up of oral PrEP users. Considering the cost and logistical complexity of HIV RNA testing, its use as a routine test during follow-up of oral PrEP users warrants reconsideration.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Pre-Exposure ProphylaxisHIV InfectionsRNA, ViralAnti-HIV AgentsHumansUnited StatesFemaleMaleAdultCohort StudiesMiddle AgedAdministration, OralHIV Antibodies

Stichwörter der Autor:innen

HIV Ag/Ab testingHIV RNA testingoral PrEPtest performance

Substanzen

RNA, ViralAnti-HIV AgentsHIV Antibodies

Autor:innen und Institutionen

  • HIV Research Branch, Division of HIV Prevention, Centers for Disease Control and Prevention, Atlanta, Georgia, USA.

ORCID-Profile: Weiming Zhu, Kevin P Delaney, Ya-Lin A Huang, Rupa R Patel, Athena P Kourtis, Karen W Hoover

Förderung

  • Intramural CDC HHS
  • centers of disease control and Prevention

Zitieren

APA

Zhu, W., Delaney, K. P., Huang, Y. A., Patel, R. R., Kourtis, A. P., & Hoover, K. W. (2025). Limited Utility of HIV RNA Testing to Monitor Oral Preexposure Prophylaxis Use: A Real-World Cohort Study—United States, 2019–2023. Clinical Infectious Diseases. https://doi.org/10.1093/cid/ciaf230

Vancouver

Zhu W, Delaney KP, Huang YA, Patel RR, Kourtis AP, Hoover KW. Limited Utility of HIV RNA Testing to Monitor Oral Preexposure Prophylaxis Use: A Real-World Cohort Study—United States, 2019–2023. Clinical Infectious Diseases. 2025. doi:10.1093/cid/ciaf230

BibTeX
@article{Zhu2025,
  author = {Zhu, Weiming and Delaney, Kevin P and Huang, Ya-Lin A and Patel, Rupa R and Kourtis, Athena P and Hoover, Karen W},
  title = {Limited Utility of HIV RNA Testing to Monitor Oral Preexposure Prophylaxis Use: A Real-World Cohort Study—United States, 2019–2023},
  journal = {Clinical Infectious Diseases},
  year = {2025},
  doi = {10.1093/cid/ciaf230}
}
Kostenlos starten →